Rights issue in Intervacc AB (SE) — SEK 225 million Healthcare Rights issue in Intervacc AB (SE) — SEK 225 million
Directed new share issue in Integrum AB (SE) — SEK 31 million Healthcare Directed new share issue in Integrum AB (SE) — SEK 31 million
Secondary sale of shares in Doktor.se (SE) — SEK 100 million Healthcare Secondary sale of shares in Doktor.se (SE) — SEK 100 million
Rights issue in Fingerprint Cards AB (SE) — SEK 160 million TMT Rights issue in Fingerprint Cards AB (SE) — SEK 160 million
Directed share issue in Faron Pharmaceuticals Ltd (FI) — EUR 12 million Healthcare Directed share issue in Faron Pharmaceuticals Ltd (FI) — EUR 12 million
Rights issue in BibbInstruments AB (SE) — SEK 28 million Healthcare Rights issue in BibbInstruments AB (SE) — SEK 28 million
Rights issue and a directed issue in SciBase Holding AB (SE) — SEK 53.4 million Healthcare Rights issue and a directed issue in SciBase Holding AB (SE) — SEK 53.4 million
Rights issue in Nimbus Group AB (SE) — SEK 356 million Consumer & Retail Rights issue in Nimbus Group AB (SE) — SEK 356 million
Sale of secondary shares in Stronghold AB (SE) – SEK 390 million FIG Sale of secondary shares in Stronghold AB (SE) – SEK 390 million
Directed new share issue in PowerCell Sweden AB (SE) — SEK 190 million Cleantech, Renewables & Infrastructure Directed new share issue in PowerCell Sweden AB (SE) — SEK 190 million
Directed new share issue in Ferroamp AB (SE) — SEK 30 million Cleantech, Renewables & Infrastructure Directed new share issue in Ferroamp AB (SE) — SEK 30 million
Placing of shares in OssDsign AB (SE) – SEK 40 million Healthcare Placing of shares in OssDsign AB (SE) – SEK 40 million